Showing 1 posts of 1 posts found.
Abbott has completed its purchase of Russia-based Veropharm in a $305 million deal as it looks to firmly establish itself …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumentis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
Hot-tub therapy tested as potential treatment for peripheral artery disease
Raimond takes helm at Nuclera